Reporting rates of adverse reactions to specialty care medicines exhibit a direct positive correlation with patient exposure: A lack of evidence for the Weber effect

Author:

Modgill Vikas1ORCID,Dormegny Léa2,Lewis David J.3

Affiliation:

1. Chief Medical Office & Patient Safety, Novartis Pharma AG Basel SWITZERLAND

2. Strasbourg University Hospital, Strasbourg, FRANCE, Pharmacovigilance Intern, Chief Medical Office & Patient Safety, Novartis Pharma AG Basel SWITZERLAND

3. Department of Clinical & Pharmaceutical Sciences University of Hertfordshire Hatfield England

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference22 articles.

1. Drug discovery in pharmaceutical industry: productivity challenges and trends

2. The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs

3. Council for International Organisations of Medical Sciences.Current challenges in pharmacovigilance: pragmatic approaches. Report of CIOMS Working Group V. Geneva: CIOMS;2001.

4. International Conference on Harmonisation.Post‐approval safety data management: Definitions and standards for expedited reporting E2D.May 2004.https://database.ich.org/sites/default/files/E2D_Guideline.pdf

5. Epidemiology in the United Kingdom of adverse drug reactions from non-steroidal anti-inflammatory drugs

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3